Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND As any drug acting on the central nervous system, sibutramine might worsen obstructive sleep apnea-hypopnea syndrome (OSAHS). This study aims to assess the risk of administering sibutramine to patients with OSAHS. METHODS We screened male, symptomatic OSAHS patients who presented consecutively at the sleep clinic. Twenty-one subjects were included, aged between 30 and 60 years, body mass index between 25 and 35kg/m(2) and apnea-hypopnea index (AHI) greater than 10AH/h. Intervention was administration of 15mg sibutramine (SB) or placebo (PL), at bedtime, for 1 month. Each patient underwent overnight polysomnograms both before entering the study and after 1 month. Outcome measures were AHI and sleep efficiency (SE). RESULTS Two patients withdrew prematurely, one due to headache, a possible side effect. Results are from 10 patients in the SB group and nine in the PL group. No significant differences were seen in any of the groups before or after treatment in measures of SE, respiratory disturbance, body weight, blood pressure, cardiac or respiratory frequency. Significant reduction occurred in the amount of REM sleep, from 19 to 13% (P=0.04) in SB group and in Epworth sleepiness score in PL and SB groups. CONCLUSION The results indicate that sibutramine does not worsen sleep or breathing during sleep in patients with OSAHS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strollo, P. J., & Rogers, R. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340207 · Cited by 1,313
Flemons, W. W. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp012849 · Cited by 362
Cited by
Drug therapy for obstructive sleep apnoea in adults
Smith, I., Lasserson, T. J., & Wright, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003002.pub2 · Cited by 132
Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures
Ashrafian, H., le Roux, C. W., Rowland, S. P., Ali, M., Cummin, A. R., Darzi, A., & Athanasiou, T. (2012) · Thorax · doi:10.1136/thx.2010.151225 · Cited by 106
The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea
Yee, B. J., Phillips, C. L., Banerjee, D., Caterson, I., Hedner, J. A., & Grunstein, R. R. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803363 · Cited by 87
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Ferland, A., Poirier, P., & Sériès, F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00167308 · Cited by 43
Metadata
- Authors
- Martinez, D., & Basile, B. R.
- Venue
- Sleep Medicine
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 6
- Issue
- 5
- Pages
- 467-470
- ISSN
- 1389-9457 (ISSN-L)
- OpenAlex
- W2164803013
- Cited by
- 18
- References
- 2
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. https://app.cochat.ai/papers/10.1016/j.sleep.2005.02.003
- The paper
- Martinez, D., & Basile, B. R. (2005). Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. Sleep Medicine. https://doi.org/10.1016/j.sleep.2005.02.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.